Skip to content
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
About Prolight
Market
Partnerships
Board of Directors and Management
Clinical Advisory Board
History
Cutting-edge technology
Vision & strategy
Products
Psyros™
MicroFlex
Patents
Investors
Press releases
Financial reports
CEO comment
Financial calendar
Stock information
AGM
Shareholders
Key figures
Corporate governance
Prospectus
Issuance page – Rights issue 2025
Media
Press releases
Investor letters
Media gallery
Presentations
Articles
Contact us
EN
SV
Press releases
Category
All
Regulatory
Non-Regulatory
Interim
Annual
Year
All
2026
2025
2024
2023
2022
2024
2024-08-30 13:48
Emergers publishes an updated analysis on Prolight Diagnostics, reaffirming a justified value of 1.1-1.2 SEK per share
2024-08-28 08:00
Prolight Diagnostics publishes half-year report, 2024
Regulatory
MAR
2024-07-03 08:00
Prolight Diagnostics presents the Psyros system at ADLM, one of the world's largest and most important diagnostics congresses
Regulatory
2024-06-04 08:35
Warrants of series TO6 were exercised to approximately 44.8 percent and Prolight Diagnostics receives approximately SEK 9.8 million
Regulatory
MAR
2024-05-29 08:00
Prolight has obtained subscription commitments for exercising warrants of series TO6 from, among others, members of the Board and management of approximately SEK 1.0 million
Regulatory
2024-05-28 08:00
Last day of trading with warrants of series TO6 in Prolight Diagnostics is today, May 28, 2024
Regulatory
2024-05-27 20:35
Annual general meeting of Prolight Diagnostics AB (publ) on 27 May 2024
Regulatory
2024-05-23 08:00
Prolight on track for clinical performance studies
2024-05-20 08:00
Prolight initiates trial at London hospital Trust supported by an NIHR i4i PDA grant
2024-05-20 07:45
The exercise period for warrants of series TO6 in Prolight Diagnostics begins today
Regulatory
Previous
Next